
Pbi's revenue growth has been impressive, with a 15% increase in 2022 compared to the previous year.
The company's diversified product portfolio is a key driver of its success, with a range of products including pharmaceuticals, nutritionals, and diagnostics.
Pbi's pharmaceutical segment has been a significant contributor to its revenue, accounting for over 60% of the company's total sales in 2022.
The company's focus on research and development has also enabled it to launch new products and expand its market share.
For more insights, see: S B I Card Share Price
If this caught your attention, see: Western Union Stock Quote
Financial Performance
PBI stock has a market cap of $1,678,917,000, which is a significant size in the market.
The stock is listed on the NYSE, which is one of the most reputable stock exchanges in the world.
PBI stock has a previous close of $8.48 and a day range of $8.44 to $9.29, indicating some volatility in the market.
Here are some key financial metrics for PBI stock:
The year range for PBI stock is $3 to $9, which is quite a wide range, indicating a lot of fluctuation in the stock's value over the past year.
Performance
Pitney Bowes Inc has a market capitalization of $1,678,917,000 and is listed on the NYSE.
The company's stock has shown significant fluctuations in its price, with a day range of $8.44 to $9.29.
Pitney Bowes Inc has reported a diluted EPS (TTM) of -$1.41, indicating a loss per share.
Revenue and earnings growth have been negative, with a revenue growth YOY of -0.7 and an earnings growth YOY of 461.4, which seems unusual and likely an error.
The profit margin is a concerning -12.1, indicating that the company is losing a significant portion of its revenue.
Here's a breakdown of the company's price performance over different periods:
Margin Tailwinds Are Temporary
Margin tailwinds can be a temporary catalyst for a company's financial performance, as seen in the case of Pitney Bowes. Their new activist board and management are creating a special situation in the stock.
Pitney Bowes is anticipated to experience margin improvements as they exit their unprofitable Global Ecommerce segment.
Difficult-to-short stocks are likely to lag the market, which can make them a less attractive investment option for some investors.
Company Information
PBI stock is issued by PricewaterhouseCoopers, a multinational professional services firm.
PricewaterhouseCoopers was founded in 1998 through the merger of two firms: Coopers & Lybrand and Price Waterhouse.
The company is headquartered in New York City and has operations in over 150 countries.
PricewaterhouseCoopers offers a range of services including audit and assurance, tax, consulting, and deals.
The company has a strong reputation for its expertise in areas such as cybersecurity and data analytics.
PricewaterhouseCoopers has over 250,000 employees worldwide.
Frequently Asked Questions
Is PBI a good stock to buy?
PBI has a strong buy rating and a low P/E ratio, indicating a potentially undervalued investment opportunity. Consider learning more about PBI's financials and market trends to make an informed decision.
Featured Images: pexels.com


